Clinical trial
Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the…
NCT00443313 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00443313 |
|---|---|
| Title | Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta |
| Official title | HPV Testing to Improve Cervical Cancer Screening in the Mississippi Delta (Mississippi Delta Project) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cervical Intraepithelial Neoplasia |
| Enrollment | 664 |
| Start date | Jan 24, 2007 |
| Completion | Jun 25, 2015 |
| First posted | Mar 5, 2007 |
| Last update posted | Apr 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: